At-home Drug of Abuse Testing Market by Product (Blood-Based Testing Kits, Breathalyzer Testing Kits, Hair-Based Testing Kits), Test Type (Cups, Strips), Drug, Distribution Channel - Global Forecast 2024-2030
The At-home Drug of Abuse Testing Market size was estimated at USD 2.68 billion in 2023 and expected to reach USD 2.88 billion in 2024, at a CAGR 7.25% to reach USD 4.38 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the At-home Drug of Abuse Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the At-home Drug of Abuse Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the At-home Drug of Abuse Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AccuBioTech Co., Ltd., Accuquik by AdvaCare Pharma USA, Atlas Medical GmbH, BioMerieux, Inc., Biopanda Reagents Ltd., BTNX Inc., Confirm BioSciences, Drägerwerk AG & Co. KGaA, Exploro Products, Identify Diagnostics by Medical Distribution Group, Inc., Innovatek Medical Inc., InTec Products, Inc., Laboratory Corporation of America Holdings, McKesson Medical-Surgical, MyDiagnostics by Phyteos Helath Systems Inc., myLAB Box Inc., OraSure Technologies, Inc., Phamatech Inc. by Caris Life Sciences, Psychemedics Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., UCP Biosciences Inc., Vitrosens Biotechnology, and Xiamen Boson Biotech Co., Ltd..
Market Segmentation & Coverage
This research report categorizes the At-home Drug of Abuse Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Blood-Based Testing Kits
Cups
Alcohol
Offline
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the At-home Drug of Abuse Testing Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the At-home Drug of Abuse Testing Market?
- What are the technology trends and regulatory frameworks in the At-home Drug of Abuse Testing Market?
- What is the market share of the leading vendors in the At-home Drug of Abuse Testing Market?
- Which modes and strategic moves are suitable for entering the At-home Drug of Abuse Testing Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. At-home Drug of Abuse Testing Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing use and production of illicit drugs
- 5.1.1.2. Government initiatives to reduce drug abuse
- 5.1.1.3. Expansion of drug production necessitates effective test measures
- 5.1.2. Restraints
- 5.1.2.1. Inability of testing products to detect small amounts of special drugs
- 5.1.3. Opportunities
- 5.1.3.1. Technological advancement and development of novel at-home drug of abuse testing devices
- 5.1.3.2. Investment in R&D activities for at-home drug of abuse testing devices
- 5.1.4. Challenges
- 5.1.4.1. Lack of awareness of at-home drug of abuse testing devices
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. At-home Drug of Abuse Testing Market, by Product
- 6.1. Introduction
- 6.2. Blood-Based Testing Kits
- 6.3. Breathalyzer Testing Kits
- 6.4. Hair-Based Testing Kits
- 6.5. Saliva-Based Testing Kits
- 6.6. Urine-Based Testing Kits
- 7. At-home Drug of Abuse Testing Market, by Test Type
- 7.1. Introduction
- 7.2. Cups
- 7.3. Strips
- 8. At-home Drug of Abuse Testing Market, by Drug
- 8.1. Introduction
- 8.2. Alcohol
- 8.3. Amphetamines
- 8.4. Benzodiazepines
- 8.5. Cocaine
- 8.6. Marijuana
- 8.7. Opioids
- 9. At-home Drug of Abuse Testing Market, by Distribution Channel
- 9.1. Introduction
- 9.2. Offline
- 9.3. Online
- 10. Americas At-home Drug of Abuse Testing Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific At-home Drug of Abuse Testing Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa At-home Drug of Abuse Testing Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. AccuBioTech Co., Ltd.
- 14.1.3. Accuquik by AdvaCare Pharma USA
- 14.1.4. Atlas Medical GmbH
- 14.1.5. BioMerieux, Inc.
- 14.1.6. Biopanda Reagents Ltd.
- 14.1.7. BTNX Inc.
- 14.1.8. Confirm BioSciences
- 14.1.9. Drägerwerk AG & Co. KGaA
- 14.1.10. Exploro Products
- 14.1.11. Identify Diagnostics by Medical Distribution Group, Inc.
- 14.1.12. Innovatek Medical Inc.
- 14.1.13. InTec Products, Inc.
- 14.1.14. Laboratory Corporation of America Holdings
- 14.1.15. McKesson Medical-Surgical
- 14.1.16. MyDiagnostics by Phyteos Helath Systems Inc.
- 14.1.17. myLAB Box Inc.
- 14.1.18. OraSure Technologies, Inc.
- 14.1.19. Phamatech Inc. by Caris Life Sciences
- 14.1.20. Psychemedics Corporation
- 14.1.21. Siemens Healthineers AG
- 14.1.22. Thermo Fisher Scientific Inc.
- 14.1.23. UCP Biosciences Inc.
- 14.1.24. Vitrosens Biotechnology
- 14.1.25. Xiamen Boson Biotech Co., Ltd.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. AT-HOME DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
- FIGURE 2. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2023 VS 2030
- FIGURE 3. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. AT-HOME DRUG OF ABUSE TESTING MARKET DYNAMICS
- FIGURE 7. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
- FIGURE 10. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
- FIGURE 12. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 14. AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AT-HOME DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. AT-HOME DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. AT-HOME DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook